Torrent Pharmaceuticals has issued unsecured Commercial Papers worth ₹300 Cr with a 92-day maturity and an interest rate of 5.93% per annum, payable upfront. The CPs will be listed on the NSE, with principal repayment due at maturity. This short-term debt raise is likely aimed at managing working capital or refinancing, helping the company optimize its liquidity position.